Biden Cuts COVID Treatment Shipments Despite States' Continued Requests
It was only a matter of days ago that President Joe Biden made a startling statement to state governors around the nation, essentially suggesting that the federal government was no longer in the pandemic-busting business.
Instead, it would be up to local leaders to handle the coronavirus crisis, including this latest surge of the omicron variant that has nearly collapsed the US COVID testing infrastructure.
Now, in another startling shortage, Biden’s team is now denying the shipment of certain COVID treatments to the states, despite their continued begging.
President Joe Biden continues ignoring state demands for more monoclonal antibody treatments, as shortages are preventing Americans seeking the treatment from accessing them.
Last week, the Biden administration paused shipments of the Regeneron and Eli Lilly treatments because of concerns about their effectiveness against the omicron variant.
The monoclonal antibody treatment Sotrovimab continues to be distributed.
There was an immediate bout of criticism.
Florida Surgeon General Joseph Ladapo directly criticized the administration in a letter on Tuesday for “actively preventing” distribution of the treatments, noting they could be used in delta variant cases of the virus.
“The sudden suspension of multiple monoclonal antibody therapy treatments from distribution to Florida removes a health care provider’s ability to decide the best treatment options for their patients in their state,” the letter read, criticizing the “shortsightedness” of the Biden administration.
Worse still, if Biden is playing chicken with the states who don’t seem to support his agenda, (while using coronavirus as the battlefield), it would like go down as one of the most despicable acts of politicking in decades.